Donor-Derived Cell-Free DNA to Diagnose Graft Rejection Post-Transplant: Past, Present and Future
Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive biomarker that is more sensitive and specific towards diagnosing any graft injury or rejection. Due to its applicability over all transplanted organs irrespective of age, sex, race, ethnicity, and the non-requirement of a donor sample, it emer...
Main Authors: | Naveen Kumar, Rashmi Rana, Devender Singh Rana, Anurag Gupta, Mohinder Pal Sachdeva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Transplantology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-3943/2/3/34 |
Similar Items
-
Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01) -
Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR
by: Tara K. Sigdel, et al.
Published: (2018-12-01) -
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
by: Daan P. Hurkmans, et al.
Published: (2019-07-01) -
CHALLENGES IN TREATMENT OF RENAL GRAFT ACUTE ANTIBODY-MEDIATED REJECTION
by: A. I. Sushkov, et al.
Published: (2016-06-01) -
Diagnosis and treatment of acute antibody-mediated rejection in renal transplant: the role of C4d and donor-specific antibody identification
by: Lúcio Roberto Requião Moura, et al.
Published: (2009-12-01)